JPWO2020055240A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020055240A5
JPWO2020055240A5 JP2021513331A JP2021513331A JPWO2020055240A5 JP WO2020055240 A5 JPWO2020055240 A5 JP WO2020055240A5 JP 2021513331 A JP2021513331 A JP 2021513331A JP 2021513331 A JP2021513331 A JP 2021513331A JP WO2020055240 A5 JPWO2020055240 A5 JP WO2020055240A5
Authority
JP
Japan
Prior art keywords
seq
cdr1
cdr2
cdr3
chain variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021513331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022500387A (ja
JP2022500387A5 (https=
Publication date
Priority claimed from NL2021589A external-priority patent/NL2021589B1/en
Application filed filed Critical
Priority claimed from PCT/NL2019/050576 external-priority patent/WO2020055240A1/en
Publication of JP2022500387A publication Critical patent/JP2022500387A/ja
Publication of JPWO2020055240A5 publication Critical patent/JPWO2020055240A5/ja
Publication of JP2022500387A5 publication Critical patent/JP2022500387A5/ja
Priority to JP2024191894A priority Critical patent/JP2025016653A/ja
Pending legal-status Critical Current

Links

JP2021513331A 2018-09-10 2019-09-05 Musk阻害 Pending JP2022500387A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024191894A JP2025016653A (ja) 2018-09-10 2024-10-31 Musk阻害

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NL2021589A NL2021589B1 (en) 2018-09-10 2018-09-10 MuSK inhibition
NL2021589 2018-09-10
NL2023119 2019-05-13
NL2023119 2019-05-13
PCT/NL2019/050576 WO2020055240A1 (en) 2018-09-10 2019-09-05 Musk inhibition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024191894A Division JP2025016653A (ja) 2018-09-10 2024-10-31 Musk阻害

Publications (3)

Publication Number Publication Date
JP2022500387A JP2022500387A (ja) 2022-01-04
JPWO2020055240A5 true JPWO2020055240A5 (https=) 2022-09-14
JP2022500387A5 JP2022500387A5 (https=) 2022-09-14

Family

ID=68138766

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021513331A Pending JP2022500387A (ja) 2018-09-10 2019-09-05 Musk阻害
JP2024191894A Pending JP2025016653A (ja) 2018-09-10 2024-10-31 Musk阻害

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024191894A Pending JP2025016653A (ja) 2018-09-10 2024-10-31 Musk阻害

Country Status (8)

Country Link
US (1) US20220002438A1 (https=)
EP (1) EP3850014A1 (https=)
JP (2) JP2022500387A (https=)
CN (1) CN113614112A (https=)
AU (1) AU2019337338A1 (https=)
CA (1) CA3112288A1 (https=)
IL (1) IL281409A (https=)
WO (1) WO2020055240A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114487448B (zh) * 2022-01-21 2022-10-18 天津天海新域生物科技有限公司 用于检测重症肌无力相关抗体的组合物、试剂盒及应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5814478A (en) 1995-12-15 1998-09-29 Regeneron Pharmaceuticals, Inc. Tyrosine kinase receptors and ligands
EP1411851B1 (en) 2001-08-03 2006-11-02 Tyco Healthcare Group LP Marker for use with a tissue marking apparatus
US7759314B2 (en) * 2001-08-15 2010-07-20 Brown University Treatment of muscular dystrophies and related disorders
US6921538B2 (en) 2002-05-10 2005-07-26 Allergan, Inc. Therapeutic treatments for neuropsychiatric disorders
US7807378B2 (en) * 2005-12-29 2010-10-05 Industrial Technology Research Institute (Itri) Method of diagnosing myasthenia gravis and kits therefor
CN101490085A (zh) * 2006-06-12 2009-07-22 特鲁比昂药品公司 具有效应功能的单链多价结合蛋白
JP2011207769A (ja) * 2010-03-29 2011-10-20 Arubion:Kk 化粧料及び皮膚外用剤
JP2014520148A (ja) * 2011-06-20 2014-08-21 セントルイス ユニバーシティ 治療のための神経筋接合部への標的化
WO2013074636A1 (en) * 2011-11-14 2013-05-23 New York University Muscle specific receptor kinase and modulation thereof
WO2015039015A2 (en) * 2013-09-13 2015-03-19 New York University Methods for treating muscle specific receptor kinase myasthenia gravis
JP7023840B2 (ja) * 2015-10-07 2022-02-22 メモリアル スローン ケタリング キャンサー センター 神経筋接合活性のモジュレーターを同定するin vitroの方法

Similar Documents

Publication Publication Date Title
JP2021191763A5 (https=)
JP2019536470A5 (https=)
CN115052893A (zh) 抗tigit抗体和使用方法
HRP20220405T1 (hr) Protutijela protiv ngf i njihova upotreba
IL273424B2 (en) Novel bispecific cd3/cd19 polypeptide complexes
RU2016100892A (ru) Антитела против tweakr и их применение
JP2018035138A5 (https=)
WO2016070051A4 (en) Combination therapy for treatment of disease
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
HRP20230344T1 (hr) Protutijela protiv sortilina i postupci njihove upotrebe
JP2013507115A5 (https=)
JP2021520201A5 (https=)
JP2024016024A5 (https=)
JP2014519334A5 (https=)
JP2015509960A5 (https=)
WO2013072523A4 (en) Bi-specific antibodies for medical use
JP2021511387A5 (https=)
JP2021520195A5 (https=)
JP2020522562A5 (https=)
JP2020502233A5 (https=)
JP2019528046A5 (https=)
JP2025148452A5 (https=)
HRP20150409T1 (hr) Lijekovi protiv pemfigusa koji sadrže anti-fas ligand antitijela
JP2018529672A5 (https=)
JPWO2020055240A5 (https=)